Latent tuberculosis: mechanisms of host and bacillus that contribute to persistent infection

被引:269
作者
Tufariello, JM
Chan, J
Flynn, JL
机构
[1] Univ Pittsburgh, Sch Med, Dept Mol Genet & Biochem, Pittsburgh, PA 15261 USA
[2] Univ Pittsburgh, Sch Med, Dept Med, Pittsburgh, PA 15261 USA
[3] Univ Pittsburgh, Sch Med, Dept Med, Pittsburgh, PA 15261 USA
[4] Univ Pittsburgh, Sch Med, Dept Immunol, Pittsburgh, PA 15261 USA
关键词
D O I
10.1016/S1473-3099(03)00741-2
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Most people infected with Mycobacterium tuberculosis contain the initial infection and develop latent tuberculosis. This state is characterised by evidence of an immune response against the bacterium (a positive tuberculin skin test) but no signs of active infection. It can be maintained for the lifetime of the infected person. However, reactivation of latent infection occurs in about 10% of infected individuals, leading to active and contagious tuberculosis. An estimated 2 billion people worldwide are infected with M tuberculosis-an enormous reservoir of potential tuberculosis cases. The establishment and reactivation of latent infection depend on several factors, related to both host and bacterium. Elucidation of the host immune mechanisms that control the initial infection and prevent reactivation has begun. The bacillus is well adapted to the human host and has a range of evasion mechanisms that contribute to its ability to avoid elimination by the immune system and establish a persistent infection. We discuss here current understanding of both host and bacterial factors that contribute to latent and reactivation tuberculosis.
引用
收藏
页码:578 / 590
页数:13
相关论文
共 179 条
[1]   EXACERBATION OF ACUTE AND CHRONIC MURINE TUBERCULOSIS BY ADMINISTRATION OF A TUMOR-NECROSIS-FACTOR RECEPTOR-EXPRESSING ADENOVIRUS [J].
ADAMS, LB ;
MASON, CM ;
KOLLS, JK ;
SCOLLARD, D ;
KRAHENBUHL, JL ;
NELSON, S .
JOURNAL OF INFECTIOUS DISEASES, 1995, 171 (02) :400-405
[2]   Infliximab downregulates interferon-γ production in activated gut T-lymphocytes from patients with Crohn's disease [J].
Agnholt, J ;
Kaltoft, K .
CYTOKINE, 2001, 15 (04) :212-222
[3]  
[Anonymous], 1964, Resistance to Tuberculosis: Experimental Studies in Native and Acquired Defense Mechanisms
[4]   PHAGOSOME-LYSOSOME INTERACTIONS IN CULTURED MACROPHAGES INFECTED WITH VIRULENT TUBERCLE-BACILLI - REVERSAL OF USUAL NONFUSION PATTERN AND OBSERVATIONS ON BACTERIAL SURVIVAL [J].
ARMSTRONG, JA ;
HART, PD .
JOURNAL OF EXPERIMENTAL MEDICINE, 1975, 142 (01) :1-16
[5]   RESPONSE OF CULTURED MACROPHAGES TO MYCOBACTERIUM-TUBERCULOSIS, WITH OBSERVATIONS ON FUSION OF LYSOSOMES WITH PHAGOSOMES [J].
ARMSTRONG, JA ;
HART, PD .
JOURNAL OF EXPERIMENTAL MEDICINE, 1971, 134 (03) :713-+
[6]  
Bean AGD, 1999, J IMMUNOL, V162, P3504
[7]   Trafficking and release of mycobacterial lipids from infected macrophages [J].
Beatty, WL ;
Rhoades, ER ;
Ullrich, HJ ;
Chatterjee, D ;
Heuser, JE ;
Russell, DG .
TRAFFIC, 2000, 1 (03) :235-247
[8]  
Beckman JS, 1996, AM J PHYSIOL-CELL PH, V271, pC1424
[9]   Susceptibility of mice deficient in CD1D or TAP1 to infection with Mycobacterium tuberculosis [J].
Behar, SM ;
Dascher, CC ;
Grusby, MJ ;
Wang, CR ;
Brenner, MB .
JOURNAL OF EXPERIMENTAL MEDICINE, 1999, 189 (12) :1973-1980
[10]   Immunopathologic effects of tumor necrosis factor alpha in murine mycobacterial infection are dose dependent [J].
Bekker, LG ;
Moreira, AL ;
Bergtold, A ;
Freeman, S ;
Ryffel, B ;
Kaplan, G .
INFECTION AND IMMUNITY, 2000, 68 (12) :6954-6961